CN110272502B - 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 - Google Patents
免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 Download PDFInfo
- Publication number
- CN110272502B CN110272502B CN201910629767.3A CN201910629767A CN110272502B CN 110272502 B CN110272502 B CN 110272502B CN 201910629767 A CN201910629767 A CN 201910629767A CN 110272502 B CN110272502 B CN 110272502B
- Authority
- CN
- China
- Prior art keywords
- cardiac troponin
- ctni
- monoclonal antibody
- polypeptide
- immunogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002163 immunogen Effects 0.000 title claims abstract description 42
- 210000004408 hybridoma Anatomy 0.000 title abstract description 30
- 102000013394 Troponin I Human genes 0.000 title abstract description 26
- 108010065729 Troponin I Proteins 0.000 title abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 23
- 230000003248 secreting effect Effects 0.000 title abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 88
- 229920001184 polypeptide Polymers 0.000 claims abstract description 85
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 85
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 26
- 102000014914 Carrier Proteins Human genes 0.000 claims description 8
- 108010078791 Carrier Proteins Proteins 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 108060003552 hemocyanin Proteins 0.000 claims description 4
- 108010049003 Fibrinogen Proteins 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 229940012952 fibrinogen Drugs 0.000 claims description 3
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 66
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 66
- 238000001514 detection method Methods 0.000 description 55
- 150000001413 amino acids Chemical group 0.000 description 34
- 239000000427 antigen Substances 0.000 description 23
- 102000036639 antigens Human genes 0.000 description 23
- 108091007433 antigens Proteins 0.000 description 23
- 102000004903 Troponin Human genes 0.000 description 20
- 108090001027 Troponin Proteins 0.000 description 20
- 230000003053 immunization Effects 0.000 description 20
- 101100537532 Rattus norvegicus Tnni3 gene Proteins 0.000 description 19
- 206010020751 Hypersensitivity Diseases 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 238000002649 immunization Methods 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 101000851334 Homo sapiens Troponin I, cardiac muscle Proteins 0.000 description 6
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000008157 ELISA kit Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000006249 magnetic particle Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 230000009610 hypersensitivity Effects 0.000 description 3
- 238000007885 magnetic separation Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 210000004988 splenocyte Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000872931 Myoporum sandwicense Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- GCYFUZJHAXJKKE-KKUMJFAQSA-N Glu-Arg-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GCYFUZJHAXJKKE-KKUMJFAQSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QHGBCRCMBCWMBJ-UHFFFAOYSA-N Ile-Glu-Ala-Lys Natural products CCC(C)C(N)C(=O)NC(CCC(O)=O)C(=O)NC(C)C(=O)NC(C(O)=O)CCCCN QHGBCRCMBCWMBJ-UHFFFAOYSA-N 0.000 description 1
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- JWQWPTLEOFNCGX-AVGNSLFASA-N Phe-Glu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWQWPTLEOFNCGX-AVGNSLFASA-N 0.000 description 1
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000010370 cell cloning Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910629767.3A CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910629767.3A CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110272502A CN110272502A (zh) | 2019-09-24 |
CN110272502B true CN110272502B (zh) | 2021-09-14 |
Family
ID=67964312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910629767.3A Active CN110272502B (zh) | 2019-07-12 | 2019-07-12 | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110272502B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110878296B (zh) * | 2019-10-16 | 2021-11-30 | 武汉伊莱瑞特生物科技股份有限公司 | 一种高敏hrp酶及其制备方法与应用 |
CN111735960A (zh) * | 2019-12-10 | 2020-10-02 | 华南农业大学 | 一种禽类肺动脉高压诊断试剂盒的制备方法 |
CN111077320B (zh) * | 2019-12-27 | 2023-06-16 | 河北省科学院生物研究所 | 一种检测鸡或鸭骨骼肌肌钙蛋白i的酶联免疫试剂盒及其制备方法与应用 |
CN111925432B (zh) * | 2020-08-18 | 2024-01-19 | 杭州启泰生物技术有限公司 | 一种心肌肌钙蛋白i重组抗原及其单克隆抗体的制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7285418B2 (en) * | 1996-06-25 | 2007-10-23 | Hytest Ltd. | Method and kit for the diagnosis of troponin I |
US6248869B1 (en) * | 1997-05-29 | 2001-06-19 | Medical Analysis Systems, Inc. | Troponin I forms and use of the same |
CN1152053C (zh) * | 1999-11-12 | 2004-06-02 | 清华大学 | 用表位多肽诱导/制备表位特异性的单克隆抗体的方法 |
CN1165548C (zh) * | 2000-03-21 | 2004-09-08 | 上海润东生物科技有限公司 | 人体心肌肌钙蛋白ⅰ的纯化方法 |
CN1312173C (zh) * | 2004-12-23 | 2007-04-25 | 复旦大学 | 一种人心肌肌钙蛋白i合成肽段s28-42及其用途 |
CN1982337A (zh) * | 2005-12-14 | 2007-06-20 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i合成多肽抗体及其制备方法与应用 |
CN101105497B (zh) * | 2006-07-13 | 2011-10-19 | 上海凯创生物技术有限公司 | 一种检测心肌肌钙蛋白i的试剂盒及其制备方法 |
WO2009118185A1 (en) * | 2008-03-27 | 2009-10-01 | Universitätsklinikum Heidelberg | Peptides derived from cardial troponin i and their use as prognostic and diagnostic markers for heart failure |
US8652788B2 (en) * | 2009-12-02 | 2014-02-18 | Abbott Laboratories | Assay for diagnosis of cardiac myocyte damage |
CN101942416B (zh) * | 2010-07-23 | 2012-03-28 | 中国医学科学院放射医学研究所 | 抗人心肌肌钙蛋白i特异性单克隆抗体及其制备方法 |
CN103173420B (zh) * | 2013-04-08 | 2015-07-15 | 菲鹏生物股份有限公司 | 可分泌抗心肌肌钙蛋白i单抗的杂交瘤细胞及应用 |
CN104020289B (zh) * | 2014-06-23 | 2015-09-30 | 宁波艾科生物科技有限公司 | 一种筛选抗原不同结合位点的单克隆抗体的方法 |
CN204165984U (zh) * | 2014-10-28 | 2015-02-18 | 广州天宝颂原生物科技开发有限公司 | 心肌肌钙蛋白i免疫层析定量检测试纸条 |
CN104833798B (zh) * | 2015-04-27 | 2016-08-24 | 杭州金溪生物技术有限公司 | 基于均相化学发光技术的快速诊断试纸条 |
CN105132383A (zh) * | 2015-07-25 | 2015-12-09 | 大庆麦伯康生物技术有限公司 | 抗cTnI单克隆抗体产生的杂交瘤 |
CN104991077B (zh) * | 2015-07-29 | 2017-09-26 | 温州煦棠生物科技有限公司 | 肌钙蛋白i竞争比浊法检测试剂盒 |
CN105567719A (zh) * | 2016-01-06 | 2016-05-11 | 北京嘉万生物技术有限公司 | cTnⅠ主要表位区的重组表达及其抗体的制备方法 |
CN107422129A (zh) * | 2017-01-15 | 2017-12-01 | 北京科跃中楷生物技术有限公司 | 一种超敏的心肌肌钙蛋白i磁微球免疫比浊检测方法及检测试剂盒 |
CN107677833A (zh) * | 2017-09-21 | 2018-02-09 | 苏州新波生物技术有限公司 | 一种心肌肌钙蛋白i磁微粒化学发光测定试剂盒及其使用方法 |
CN109912713B (zh) * | 2019-01-08 | 2022-09-13 | 美康生物科技股份有限公司 | 用于免疫诊断试剂配制的肌钙蛋白i抗体的制备方法及获得的菌株 |
CN109709323A (zh) * | 2019-02-15 | 2019-05-03 | 深圳上泰生物工程有限公司 | 高敏心肌肌钙蛋白i磁微粒化学发光免疫检测试剂盒、制备方法及用途 |
-
2019
- 2019-07-12 CN CN201910629767.3A patent/CN110272502B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110272502A (zh) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110272502B (zh) | 免疫原、分泌抗心肌肌钙蛋白i单克隆抗体的杂交瘤细胞及制备方法、单克隆抗体及应用 | |
CN103940986A (zh) | 肌钙蛋白i 特定位点抗体制备及其检测试剂盒 | |
CN102633864A (zh) | 一种gpc3抗原多肽,抗gpc3的多克隆抗体及其应用 | |
CN113004412B (zh) | 胃蛋白酶原i单克隆抗体及其应用 | |
CN109912713B (zh) | 用于免疫诊断试剂配制的肌钙蛋白i抗体的制备方法及获得的菌株 | |
CN112094338B (zh) | 氨基末端脑钠肽前体多肽、偶联蛋白 | |
CN113683702A (zh) | 条纹斑竹鲨单域抗体的多克隆抗体的制备方法及其应用 | |
CN114369160B (zh) | 结合抗繆勒氏管激素amhn二聚体蛋白的高亲和力兔单抗 | |
CN109627306B (zh) | 水稻籽粒谷蛋白GluA2亚基的抗原表位、其抗体及应用 | |
CN107478848B (zh) | 定量检测人NT-proBNP的试剂盒及其制备方法 | |
CN101880316B (zh) | 一种人rbpms多肽及其抗体制备方法 | |
EP3988564A1 (en) | Leptin immunogen, hybridoma cell, monoclonal antibody, polyclonal antibody and use thereof | |
US20200057082A1 (en) | Method of measuring cholesterol levels by using immunogenic method | |
CN113832132B (zh) | 一种烙铁头svmp蛋白特异性短肽、抗烙铁头svmp蛋白抗体和蛇伤检测试剂盒 | |
KR20090058327A (ko) | 마이코플라즈마 뉴모니아성 폐렴 진단을 위한 재조합단백질 및 이를 이용한 진단 키트 | |
CN102336814A (zh) | 一种用于制备抗肝脏肿瘤标志物ck-19抗体的多肽序列、多克隆抗体与应用 | |
CN113956355B (zh) | 抗人脑利钠肽(bnp)兔单克隆抗体及其应用 | |
EP3537152A1 (en) | Immunoassay method for determining renin concentration | |
CN104744581B (zh) | 一种弓形虫蛋白TgVP1胞内区抗原多肽、抗弓形虫TgVP1的多克隆抗体及其应用 | |
CN113956360A (zh) | 一种chi3l1单克隆抗体及其制备方法和应用 | |
CN101928332A (zh) | 一种人hnrpa0多肽及其抗体制备方法 | |
CN107056931B (zh) | 一种抗原肽和nod1抗体及应用、制备方法和试剂盒 | |
CN108752480B (zh) | 一种免疫原组合物、其制备方法及其用途 | |
CN114891104B (zh) | 识别amh的单克隆抗体及其应用 | |
CN110240644B (zh) | 人生长激素受体突变体、人生长激素免疫原、多克隆抗体及检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221226 Address after: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN YHLO BIOTECH Co.,Ltd. Patentee after: Shenzhen Zhuoren Biotechnology Co.,Ltd. Address before: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN YHLO BIOTECH Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240311 Address after: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN YHLO BIOTECH Co.,Ltd. Country or region after: China Address before: 518116 Yahui Long Biotechnology Plant, Baolong Street, Longgang District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN YHLO BIOTECH Co.,Ltd. Country or region before: China Patentee before: Shenzhen Zhuoren Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |